Home
Drugs
Paclitaxel
Clinical Trials

Clinical Trials Related to Paclitaxel

Related studies linked through entity extraction aliases.

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Status: UNKNOWN
Phase: PHASE1/PHASE2

A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies

Status: TERMINATED
Phase: PHASE1/PHASE2

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Status: COMPLETED
Phase: PHASE2

Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

Status: COMPLETED
Phase: PHASE1

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Status: COMPLETED
Phase: PHASE3

Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

Status: UNKNOWN
Phase: PHASE2

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter

Status: COMPLETED
Phase: PHASE2

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Status: COMPLETED
Phase: PHASE2

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Status: UNKNOWN
Phase: PHASE2

A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer

Status: WITHDRAWN
Phase: PHASE1

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

Status: COMPLETED
Phase: PHASE2

Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Status: TERMINATED
Phase: PHASE2

Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.

Status: COMPLETED
Phase: PHASE1/PHASE2

Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Status: TERMINATED
Phase: PHASE3

Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer

Status: UNKNOWN
Phase: PHASE2

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Status: COMPLETED
Phase: PHASE2